ENTITY

Micurx Pharmaceuticals (0276457D US)

1
Analysis
Health CareChina
Micurx Pharmaceuticals Inc. discovers and develops novel antibiotics to combat drug-resistant bacterial infections. The Company offers a pipeline of discovery and development programs for the treatment of Gram-positive bacteria, Gram-negative bacteria and fungal infections. Micurx Pharmaceuticals operates and markets to customers in the United States and China.
more
Refresh
19 Sep 2018 16:16

MicuRx Pharma (盟科医药) IPO: Betting on Single Drug in the Not so Attractive Antibiotic Segment

MicuRx Pharma is the fourth biotech company to file with Hong Kong Stock Exchange for a listing under the new rule. In this insight, we will look...

Logo
685 Views
Share
No more insights
x